Global Pharmaceuticals & Biotech Stable Growth Stocks

Sunshine Guojian Pharmaceutical (Shanghai)

Market Cap: CN¥42.7b

A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs.

Chugai Pharmaceutical

Market Cap: JP¥11.5t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

Rubicon Research

Market Cap: ₹285.5b

Operates as a specialty pharmaceutical company in India, the United States, and internationally.

3SBio

Market Cap: HK$44.4b

An investment holding company, engages in the development, production, marketing, and sale of biopharmaceutical products in the People’s Republic of China, the United States, and internationally.

PharmaResearch

Market Cap: ₩4.2t

Operates as a biopharmaceutical company primarily in South Korea.

Orion Oyj

Market Cap: €11.1b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

PharmaEssentia

Market Cap: NT$580.2b

A biopharmaceutical company engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API, and new drug patterns developments in the Americas, Europe, Asia, and Taiwan.

Emcure Pharmaceuticals

Market Cap: ₹353.2b

Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.

Ajanta Pharma

Market Cap: ₹454.7b

A pharmaceutical formulation company engages in the development, manufacture, and marketing of specialty pharmaceutical finished dosages.

Incyte

Market Cap: US$25.8b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

Samsung BiologicsLtd

Market Cap: ₩71.7t

Together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.

Neuland Laboratories

Market Cap: ₹298.9b

Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.

WuXi AppTec

Market Cap: CN¥484.8b

An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.

Shenyang Xingqi PharmaceuticalLtd

Market Cap: CN¥14.2b

Engages in the research, development, production, and sale of ophthalmic drugs in the People’s Republic of China.

Acutaas Chemicals

Market Cap: ₹259.4b

Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.

ACADIA Pharmaceuticals

Market Cap: US$5.1b

A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.

AstraZeneca

Market Cap: UK£187.5b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

Exelixis

Market Cap: US$13.3b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Hanmi Pharm

Market Cap: ₩5.3t

A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.

HitGen

Market Cap: CN¥14.5b

Operates as a drug discovery research platform for small molecules and nucleic acid drugs in China and internationally.

Sumitomo Pharma

Market Cap: JP¥633.2b

Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia.

Galderma Group

Market Cap: CHF 39.5b

Operates as a dermatology company worldwide.

Kiniksa Pharmaceuticals International

Market Cap: US$6.1b

A biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally.

CareDx

Market Cap: US$2.4b

Provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally.

Kyowa Kirin

Market Cap: JP¥1.3t

Engages in the research, development, manufacturing, and marketing of pharmaceuticals in Japan, the Americas, Europe, Asia, and internationally.

Astellas Pharma

Market Cap: JP¥4.3t

Engages in the research, development, manufacture, sale, and supply of pharmaceuticals in Japan and internationally.

Granules India

Market Cap: ₹212.7b

Manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), finished dosages (FDs), and peptides CDMO in India and internationally.

UCB

Market Cap: €41.5b

A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.

Hansoh Pharmaceutical Group

Market Cap: HK$200.6b

An investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.

Neurocrine Biosciences

Market Cap: US$15.5b

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally.

Agilent Technologies

Market Cap: US$44.1b

Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.

Betta Pharmaceuticals

Market Cap: CN¥21.5b

Researches and develops, manufactures, and markets medicines for the treatment of cancer in China and internationally.

Lupin

Market Cap: ₹1.0t

Operates as a pharmaceutical company in India, the United States, and internationally.

Celltrion

Market Cap: ₩44.1t

A biopharmaceutical company, engages in the development, production, and sale of development, production, and sale of medicinal products.

Vericel

Market Cap: US$2.2b

A commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America.

Lonza Group

Market Cap: CHF 40.9b

Operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.